company background image
7AC logo

Acarix DB:7AC Stock Report

Last Price

€0.02

Market Cap

€16.1m

7D

17.6%

1Y

-36.3%

Updated

26 Mar, 2024

Data

Company Financials +

7AC Stock Overview

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out in Sweden and internationally.

7AC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Acarix AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Acarix
Historical stock prices
Current Share Pricekr0.02
52 Week Highkr0.055
52 Week Lowkr0.014
Beta1.42
1 Month Change-8.68%
3 Month Change29.03%
1 Year Change-36.31%
3 Year Change-81.57%
5 Year Change-94.46%
Change since IPO-99.12%

Recent News & Updates

Recent updates

Shareholder Returns

7ACDE Medical EquipmentDE Market
7D17.6%-0.6%1.6%
1Y-36.3%2.8%6.4%

Return vs Industry: 7AC underperformed the German Medical Equipment industry which returned 2.8% over the past year.

Return vs Market: 7AC underperformed the German Market which returned 6.4% over the past year.

Price Volatility

Is 7AC's price volatile compared to industry and market?
7AC volatility
7AC Average Weekly Movement36.4%
Medical Equipment Industry Average Movement5.0%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 7AC's share price has been volatile over the past 3 months.

Volatility Over Time: 7AC's weekly volatility (36%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
200920Aamir Mahmoodhttps://www.acarix.com

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out in Sweden and internationally. It offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced AI to analyze the patient's coronary blood flow. The company was founded in 2009 and is headquartered in Malmö, Sweden.

Acarix AB (publ) Fundamentals Summary

How do Acarix's earnings and revenue compare to its market cap?
7AC fundamental statistics
Market cap€16.08m
Earnings (TTM)-€6.79m
Revenue (TTM)€544.68k

29.5x

P/S Ratio

-2.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7AC income statement (TTM)
Revenuekr6.24m
Cost of Revenuekr944.00k
Gross Profitkr5.30m
Other Expenseskr83.14m
Earnings-kr77.84m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 23, 2024

Earnings per share (EPS)-0.11
Gross Margin84.87%
Net Profit Margin-1,247.22%
Debt/Equity Ratio0%

How did 7AC perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.